Assessing the outcome of systemic tissue plasminogen activator for the management of venous and arterial thrombosis in pediatrics.
This study sought to ascertain the outcomes of systemic thrombolytic therapy used in a cohort of infants and children. Complete thrombus resolution was achieved in 81% of patients with arterial thromboses (n=16) compared to 0% of children with venous thromboses (n=10). A major bleeding rate of 11.5% occurred across the entire cohort (n=3, all arterial). In our cohort, no patient with venous thromboembolism achieved complete resolution of their thrombosis after thrombolytic therapy. More cohort studies reporting the outcome of uniform protocols of thrombolytic therapy in children are required.
Newall
Fiona
F
Clinical Haematology Department, Royal Children's Hospital, Parkville, VIC, Australia. fiona.newall@rch.org.au
Browne
Martin
M
Savoia
Helen
H
Campbell
Janine
J
Barnes
Chris
C
Monagle
Paul
P
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D015331:Cohort Studies; D005343:Fibrinolytic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D012074:Remission Induction; D012189:Retrospective Studies; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage* / Q000009:adverse effects; D016896:Treatment Outcome; D020246:Venous Thrombosis / Q000150:complications / Q000188:drug therapy*
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator